Submit Deal

Submit Deal

Cover Image LOGOS CAPITAL

LOGOS CAPITAL

LOGOS CAPITAL

HQ - Miami

Summary

Logos Capital is a global investment firm focused on impact investing and biotechnology.

Deals Overview

Total Deals37

Valued Deals35

Total Value£ 4.38 B

Avg. Deal Size£ 125 M

Market Context

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2026 Datasite

MergerLinks - LOGOS CAPITAL

Sort

26 Aug 2020|United States|Biotechnology

Target: KINNATE BIOPHARMA

Bidder: NEXTECH INVEST

9 Service Providers

1 Target | 8 Bidder

9 Dealmakers

1 Target | 8 Bidder

£ 74 M

Value

30 Mar 2020|United States|Pharmaceuticals

Target: ANNEXON

Bidder: ADAGE CAPITAL MANAGEMENT

15 Service Providers

3 Target | 12 Bidder

16 Dealmakers

4 Target | 12 Bidder

£ 81 M

Value

16 Jun 2020|United States|Biotechnology

Target: C4 THERAPEUTICS INC

Bidder: RTW INVESTMENTS

16 Service Providers

5 Target | 11 Bidder

26 Dealmakers

3 Target | 22 Bidder

£ 119 M

Value

08 Jul 2020|United States|Biotechnology

Target: VELOSBIO INC

Bidder: CORMORANT ASSET MANAGEMENT

14 Service Providers

2 Target | 12 Bidder

16 Dealmakers

2 Target | 14 Bidder

£ 105 M

Value

29 Oct 2020|China|Pharmaceuticals

Target: LIANBIO

Bidder: LOGOS CAPITAL

18 Service Providers

3 Target | 15 Bidder

18 Dealmakers

3 Target | 16 Bidder

£ 239 M

Value

28 Oct 2020|United States|Biotechnology

Target: MIRAGEN THERAPEUTICS

Bidder: VENROCK ASSOCIATES

16 Service Providers

5 Target | 11 Bidder

19 Dealmakers

5 Target | 14 Bidder

£ 70 M

Value

05 Jan 2021|United States|Biotechnology

Target: IKENA ONCOLOGY

Bidder: OMEGA FUNDS

15 Service Providers

3 Target | 12 Bidder

15 Dealmakers

3 Target | 12 Bidder

£ 88 M

Value

11 Jan 2021|China|Pharmaceuticals

Target: VISEN PHARMACEUTICALS

Bidder: ORBIMED PE

12 Service Providers

1 Target | 11 Bidder

13 Dealmakers

1 Target | 12 Bidder

£ 111 M

Value

16 Feb 2021|United Kingdom|Pharmaceuticals

Target: CENTESSA PHARMACEUTICALS

Bidder: JANUS HENDERSON INVESTORS

20 Service Providers

5 Target | 15 Bidder

27 Dealmakers

9 Target | 19 Bidder

£ 179 M

Value

26 Feb 2021|United States|Biotechnology

Target: ARTIVA BIOTHERAPEUTICS

Bidder: ACUTA CAPITAL

16 Service Providers

3 Target | 13 Bidder

16 Dealmakers

3 Target | 13 Bidder

n/a

Value

30 Mar 2021|United States|Biotechnology

Target: PYXIS ONCOLOGY

Bidder: RTW INVESTMENTS

5 Service Providers

2 Target | 3 Bidder

5 Dealmakers

2 Target | 3 Bidder

£ 110 M

Value

30 Mar 2021|United States|Biotechnology

Target: OMEGA THERAPEUTICS

Bidder: LOGOS CAPITAL

10 Service Providers

2 Target | 8 Bidder

12 Dealmakers

4 Target | 8 Bidder

£ 91 M

Value